Decreased expression of angiotensin-converting enzyme in the airway epithelium of asthmatic subjects is associated with eosinophil inflammation

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 2 I, 1999, Pages 402-410

  Roisman, Gabriel L ^a   Danel, Claire J ^b   Lacronique, Jacques G ^a   Alhenc Gelas, François ^c   Dusser, Daniel J ^a  

^a UFR Cochin Port Royal ^*  (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c INSERM   (France)

Author keywords

Airway epithelium; Asthma; Bradykinin; Inflammation; Kininase II

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE; METHACHOLINE;

ADULT; ARTICLE; ASTHMA; BRONCHUS BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; STEROID THERAPY;

EID: 0032827477     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70385-4     Document Type: Article

References (39)

1. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990;142:434-57.
2. Barnes PJ, Baraniuk JN, Belvisi MG. Neuropeptides in the respiratory tract. Part II. Am Rev Respir Dis 1991;144:1391-9.
3. Barnes PJ. Bradykinin and asthma. Thorax 1992;47:979-83.
4. Erdös E. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990;16:363-70.
5. Johnson AR, Ashton J, Schulz WW, Erdös EG. Neutral metalloendopeptidase in human lung tissue and cultured cells. Am Rev Respir Dis 1985;132:564-8.
6. Skidgel RA, Erdös EG. The broad substrate specificity of human angiotensin I converting enzyme. Clin Exp Hypertens 1987;A9:243-59.
7. Christiansen SC, Proud D, Cochrane CG. Detection of tissue kallikrein in bronchoalveolar lavage fluid of asthmatic subjects. J Clin Invest 1987;79:188-97.
8. Christiansen SC, Proud D, Sarnoff RB, Juergens U, Cochrane CG, Zuraw BL. Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. Am Rev Respir Dis 1992;145:900-5.
9. Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and β-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992;90:646-52.
10. Lurie A, Nadel J, Roisman G, Siney H, Dusser D. Role of neutral endopeptidase and angiotensin converting enzyme in the modulation of the nasal response to substance P in patients with allergic rhinitis and in healthy volunteers. Am J Respir Grit Care Med 1994;149:113-7.
11. Benessiano J, Crestani B, Mestari F, Klouche W, Neukirch F, Hacein-Bey S, et al. High frequency of deletion polymorphism of the angiotensin-converting enzyme gene in asthma. J Allergy Clin Immunol 1997;99:537.
12. Cockcroft DW, Hargreave FE. Airway hyperresponsiveness: definition, measurement, and clinical relevance. In: Kaliner MA, Barnes PJ, Persson CGA, editors. Asthma: its pathology and treatment. New York: Marcel Dekker, Inc; 1991. p. 51-72.
13. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-43.
14. Roisman GL, Lacronique JG, Desmazes-Dufeu N, Carré C, Le Cae A, Dusser DJ. Airway responsiveness to bradykinin is related to eosinophilic inflammation in asthma. Am J Respir Crit Care Med 1996;153:381-90.
15. Polosa R, Holgate ST. Comparative airway responses to inhaled bradykinin, kallidin, and [des-Arg9] bradykinin in normal and asthmatic subjects. Am Rev Respir Dis 1990;142:1367-71.
16. McElroy DA. Laboratory methods in histotechnology. 1st ed. Washington (DC): American Registry of Pathology; 1992.
17. Saetta M, Maestrelli P, Turato G, Mapp CE, Milani G, Pivirotto F, et al. Airway wall remodeling after cessation of exposure to isocyanates in sensitized asthmatic subjects. Am J Respir Grit Care Med 1995;151:489-94.
18. Danilov SM, Faerman AI, Printseva OY, Martynov AV, Sakharov IY, Trakht IN. Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies. Histochemistry 1987;87:487-90.
19. Sibony M, Gase J-M, Soubrier F, Alhenc-Gelas F, Corvol P. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension 1993;21:827-35.
20. Eiser NM, Kerrebijn KF, Quanjer PH. SEPCR working group "bronchial hyperreactivity": guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents. Bull Eur Physiopathol Respir 1983;19:495-514.
21. Zar JH. Biostatistical Analysis. Englewood Cliffs (NJ): Prentice-Hall; 1984.
22. Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 1992;340:1248-51.
23. Lundberg J, Hökfelt T, Martling C-R, Saria A, Cuello C. Substance P-immunoreactive sensory nerves in the lower repiratory tract of various mammals including man. Cell Tissue Res 1984;235:251-61.
24. Fuller R, Dixon C, Cuss F, Barnes P. Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis 1987;135:176-80.
25. Coulter D, Edwards I. Cough associated with captopril and enalapril. BMJ 1987;294:1521-3.
26. Lucchini R, Facchini F, Turato G, Saetta M, Caramori G, Ciaccia A, et al. Increased VIP-containing fibers in the mucous glands of subjects with chronic bronchitis. Am J Respir Crit Care Med 1997;156:1963-8.
27. Costerousse O, Jaspard E, Alhenc-Gelas F Molecular and genetic aspects of dipeptidyl carboxypeptidase I (the angiotensin I converting enzyme). Expression in the immune system. Adv Neuroimmunol 1993;3:217-26.
28. Spillantini MG, Sicuteri F, Salmon S, Malfroy B. Characterization of endopeptidase 3.4.24.11 ("enkephalinase") activity in human plasma and cerebrospinal fluid. Biochem Pharmacol 1990;39:1353-6.
29. Dusser DJ, Nadel JA, Sekizawa K, Graf PD, Borson DB. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea. J Pharmacol Exp Ther 1988;244:531-6.
30. Kroegel C, Giembycz M, Barnes P. Characterization of eosinophil activation by peptides. Differential effects of substance P, melitin, and f-metleu-phe. J Immunol 1990;145:2581-7.
31. De Simone C, Ferrari M, Ferrareli G, Rumi C, Pugnaloni L, Sorice F The effects of substance P on human eosinophil receptors and functions. Ann N Y Acad Sci 1987;496:226-32.
32. Wiedermann F, Kahler C, Reinish N, Wiedermann C. Induction of normal human eosinophil migration in vitro by substance P. Acta Haematol 1993;89:213-5.
33. Chen X, Catravas JD. Neutrophil-mediated endothelial angiotensin-converting enzyme dysfunction: role of oxygen-derived free radicals. Am J Physiol 1993;265:L243-9.
34. Friedland J, Setton C, Silverstein E. Angiotensin converting enzyme: induction by steroids in rabbit alveolar macrophages in culture. Science 1977;197:64-5.
35. Katayama M, Nadel JA, Piedemonte G, McDonald DM. Peptidase inhibitors reverse steroid-induced suppression of neutrophil adhesion in rat tracheal blood vessels. Am J Physiol 1993;264:L316-22.
36. Piedimonte G, McDonald DM, Nadel JA. Neutral endopeptidase and kininase II mediate glucocorticoid inhibition of neurogenic inflammation in the rat trachea. J Clin Invest 1991;88:40-4.
37. Ichinose M, Barnes P. Bradykinin-induced airway microvascular leakage and bronchoconstriction are mediated via a bradykinin B2 receptor. Am Rev Respir Dis 1990;142:1104-7.
38. Corfield D, Webber S, Hanafi Z, Widdicombe J. The actions of bradykinin and lys-bradykinin on tracheal blood flow and smooth muscle in anesthetized sheep. Pulm Pharmacol 1991;4:85-90.
39. Baraniuk JN, Lundgren JD, Mizoguchi H, Peden D, Gawin A, Merida M, et al. Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo. Am Rev Respir Dis 1990;141:706-14.